The US depth of anesthesia monitoring market
is projected to grow from USD 141 million in 2018 to USD 170 million by
2024, at a CAGR of 3.2% during the forecast period. The growth of this
market can largely be attributed to the rising patient pool in hospitals
and the increasing number of surgeries in the US. However, depth of
anesthesia monitoring devices are expensive and have considerably high
installation and maintenance costs. Owing to this, their adoption is
limited in small outpatient settings and clinics.
To know about the assumptions considered for the study Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243124200
The prominent players operating in this market are Masimo Corporation
(US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), GE
Healthcare (US), Mennen Medical Ltd. (Israel), Medtronic Public Limited
Company (Ireland), and Philips Healthcare (Netherlands). These players
focused on strategic partnerships, acquisitions, and the launch of new
products to increase their presence and reach in the US depth of
anesthesia monitoring market.
GE Healthcare (US) is the only player that offers devices that can
measure Entropy for DOA monitoring and holds a major share in the US
depth of anesthesia monitoring market. GE Healthcare has its proprietary
Entropy technology designed to provide information on the state of the
central nervous system during general anesthesia. The company also
offers the E-BIS module, which uses the BIS expanded performance (BIS
XP) technology to measure the effects of anesthetics and sedatives on
the brain with a four-electrode Quatro sensor. The company serves
customers in more than 130 countries across the Americas, Europe, Asia,
the Middle East, and Africa.
Medtronic plc (Ireland) is one of the leading manufacturers of depth of
anesthesia monitoring sensors and standalone devices. In standalone
devices, Medtronic plc holds 100% of the market, being the only player
providing BIS monitoring systems. The company has a number of strategic
OEM partners and has partnered with different patient monitoring
equipment manufacturers to deliver better care through multi-parameter
and multi-use patient monitors and devices.
Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=243124200
Masimo Corporation (US) holds a large share of the market, in both value
and volume terms. This is mainly due to its broad range of offerings,
which covers the Masimo Open Connect (MOC-9) modules, including
Next-generation SedLine Brain Function Monitoring. Masimo’s Root
Platform is a powerful, expandable patient monitoring and connectivity
hub that integrates an array of technologies, devices, and systems to
provide multimodal monitoring and connectivity solutions in a single
clinician-centric platform.